Physician profile
Benjamin J Kulow
NPI 1063855898
$3,077.75
in general payments reported to CMS, 2019-2025
10 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,495 · 2020: $29.49 · 2021: $142 · 2022: $141 · 2024: $82.71 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.06 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,102.79 | 2019-2021 | |
| Stryker Corporation | $327.30 | 2019 | |
| W. L. Gore & Associates, INC. | $140.83 | 2022 | |
| Abbvie INC. | $119.35 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $101.82 | 2019 | |
| Zimmer Biomet Holdings, INC. | $101.12 | 2021 | |
| Medtronic, INC. | $82.71 | 2024 | Signia |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Takeda Pharmaceuticals U.S.A., INC. | $17.08 | 2021 | |
| Covidien LP | $16.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Kulow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.